Equity Capital Markets

Company · CIK 1631650

Aimmune Therapeutics, Inc.

CIK1631650 (SEC EDGAR)
Industry (SIC)2834 — Pharmaceutical Preparations
Incorporated inDE
Business addressCA
Listedno ticker on SEC record today
First annual or quarterly report2015-08-31

Offerings

3 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-213499
ShelfEffective
 2016-09-022020-10-143
333-222333
ShelfEffective
 2017-12-282020-10-144
333-205501
IPOFinal prospectus
 2015-07-062015-08-065

Filings

13
FiledFilingRegistrationAccession
2020-10-14EFFECTDeclared effective 333-2223339999999995-20-002835
2020-10-14EFFECTDeclared effective 333-2134999999999995-20-002834
2018-02-22424B5Shelf takedown 333-2223330001193125-18-054140
2018-02-20424B5Shelf takedown 333-2223330001193125-18-050506
2017-12-28S-3ASRShelf registered 333-2223330001193125-17-381647
2016-09-15EFFECTDeclared effective 333-2134999999999995-16-005702
2016-09-02S-3Shelf registered 333-2134990001193125-16-700931
2015-08-06424B4Final prospectus 333-2055010001193125-15-280071
2015-08-05EFFECTDeclared effective 333-2055019999999995-15-002184
2015-08-05S-1/AAmendment 333-2055010001193125-15-277836
2015-07-27S-1/AAmendment 333-2055010001193125-15-263434
2015-07-06S-1Registration filed 333-2055010001193125-15-245362
2015-06-04DRSDraft made public 377-010320000950123-15-006774

All filings of this company · CSV